stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Phio Pharmaceuticals CorpPHIO
$0.9032.61%0.023
Dopo l'orario di chiusura: 0.84-0.06 -6.98%

Phio Pharmaceuticals Corp (PHIO)

Date: 2026-11-03 16:00O: 0.8700H: 0.9197L: 0.8700C: 0.9030Vol: 33.70k
Precedente Chiudi:
$0.88
Aprire:
$0.87
Volume 24 ore:
33,013
Volume relativo:
0.71
Capitalizzazione di mercato:
$10.49M
Reddito:
$153.00K
Utile/perdita netta:
-$10.93M
Rapporto P/E:
-
EPS:
-$1.44
Flusso di cassa netto:
-$10.72M
1W Prestazione:
+1.32%
1M Prestazione:
-8.33%
6M Prestazione:
-20.79%
1Y Prestazione:
-51.45%
Intervallo 1D:
$0.87$0.9197
Intervallo di 1 settimana:
$0.85$0.9197
Portata 52W:
$0.8127$4.19

Profilo aziendale di Phio Pharmaceuticals Corp (PHIO)

Nome
Phio Pharmaceuticals Corp
Settore
Healthcare
Industria
Biotechnology
Telefono
(508) 767-3861
Indirizzo
411 SWEDELAND ROAD, KING OF PRUSSIA, MA, USA
Dipendente
6
Prossima data di guadagno
2026-11-12
Ultimi documenti SEC
SEC
Discussioni di PHIO su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Phio Pharmaceuticals Corp Azioni (PHIO) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2025-06-05ResumedH.C. WainwrightBuy
2020-08-05IniziatoH.C. WainwrightBuy

Phio Pharmaceuticals Corp Azioni (PHIO) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)--0.000.000.00
Research and development USD (M)4.623.646.337.018.89
Operating expenses USD (M)9.227.3910.8211.4613.51
Operating income USD (M)-9.22-7.39-10.82-11.46-13.51
Income before tax USD (M)---10.83-11.48-13.29
Income tax expense USD (M)0.000.000.000.000.00
Net income USD (M)-8.70-7.15-10.83-11.48-13.29
Basic EPS USD/shares-1.45-9.08-5.20-10.10-
Diluted EPS USD/shares--9.08-5.20-10.10-
Basic weighted shares shares (M)5.980.792.081.14-
Diluted weighted shares shares (M)-0.792.081.14-

Phio Pharmaceuticals Corp Azioni (PHIO) insider trading

  • Director
    Transazione
    Buy
    Costo
    $1.04
    #Azioni
    5,000
    Valore ($)
    5,200
    #Azioni Totale
    42,000
  • Director
    Transazione
    Buy
    Costo
    $1.03
    #Azioni
    5,000
    Valore ($)
    5,150
    #Azioni Totale
    37,000
  • Director
    Transazione
    Buy
    Costo
    $1.01
    #Azioni
    6,500
    Valore ($)
    6,583
    #Azioni Totale
    64,151
  • Chairman, Pres. & CEO
    Transazione
    Buy
    Costo
    $1.03
    #Azioni
    2,000
    Valore ($)
    2,058
    #Azioni Totale
    364,871
  • Director
    Transazione
    Buy
    Costo
    $1.03
    #Azioni
    12,000
    Valore ($)
    12,360
    #Azioni Totale
    57,651
  • Director
    Transazione
    Buy
    Costo
    $1.14
    #Azioni
    15,000
    Valore ($)
    17,100
    #Azioni Totale
    15,000
  • Chairman, Pres. & CEO
    Transazione
    Buy
    Costo
    $1.06
    #Azioni
    10,000
    Valore ($)
    10,600
    #Azioni Totale
    431,421
  • Chairman, Pres. & CEO
    Transazione
    Buy
    Costo
    $0.99
    #Azioni
    10,000
    Valore ($)
    9,900
    #Azioni Totale
    421,421
  • Chairman, Pres. & CEO
    Transazione
    Buy
    Costo
    $1.03
    #Azioni
    5,000
    Valore ($)
    5,150
    #Azioni Totale
    291,421
  • Chairman, Pres. & CEO
    Transazione
    Buy
    Costo
    $1.02
    #Azioni
    5,000
    Valore ($)
    5,100
    #Azioni Totale
    286,421
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Plott Ronald ToddDirectorSep 29 '26Buy$1.045,0005,20042,000
Plott Ronald ToddDirectorSep 28 '26Buy$1.035,0005,15037,000
BRADFORD PATRICIA ADirectorSep 24 '26Buy$1.016,5006,58364,151
Bitterman Robert JChairman, Pres. & CEOSep 22 '26Buy$1.032,0002,058364,871
BRADFORD PATRICIA ADirectorSep 15 '26Buy$1.0312,00012,36057,651
Plott Ronald ToddDirectorAug 19 '26Buy$1.1415,00017,10015,000
Bitterman Robert JChairman, Pres. & CEOAug 18 '26Buy$1.0610,00010,600431,421
Bitterman Robert JChairman, Pres. & CEOJun 26 '26Buy$0.9910,0009,900421,421
Bitterman Robert JChairman, Pres. & CEODec 31 '25Buy$1.035,0005,150291,421
Bitterman Robert JChairman, Pres. & CEODec 23 '25Buy$1.025,0005,100286,421

Phio Pharmaceuticals Corp Borsa (PHIO) Ultime notizie

Oct 06, 2026
Oct 06, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Sep 30, 2026
Sep 30, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 25, 2026
Sep 25, 2026
Sep 25, 2026
Sep 25, 2026
Sep 23, 2026
Sep 23, 2026
Sep 23, 2026
Sep 23, 2026
Sep 18, 2026
Sep 18, 2026
Sep 17, 2026
Sep 17, 2026
Sep 16, 2026
Sep 16, 2026
Sep 15, 2026
Sep 15, 2026
Sep 15, 2026
Sep 15, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 11, 2026
Sep 11, 2026
Sep 11, 2026
Sep 11, 2026
Aug 30, 2026
Aug 30, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 14, 2026
Aug 14, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 10, 2026
Aug 10, 2026
Aug 08, 2026
Aug 08, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026

Simile a PHIO